Author

M. Adner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Assay:flow cytometry· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. Egesten· 1 shared A. Ravindran· 1 shared A. Wintersand· 1 shared A.-C. Orre· 1 shared B. Murrell· 1 shared C. A. Tibbitt· 1 shared C. Dong· 1 shared C. Kalderen· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Egesten

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

OGG1 inhibitor TH5487 alleviates allergic airway inflammation in mice

L. Tanner, J. Bergwik, R. K. Bhongir, L. Pan, C. Dong, C. Kalderen, T. Helleday, I. Boldogh, M. Adner, A. Egesten

This study shows that TH5487, an OGG1 inhibitor, reduces allergic airway inflammation in mice by decreasing mucus production, immune cell recruitment, and proinflammatory cytokines.

bioRxiv · May 17, 2022 · PreprintPharmacology & Toxicology

Immunoprofiling reveals novel mast cell receptors and a continuous nature of human lung mast cell heterogeneity

E. Rönnberg, D. Zhong Hao Boey, A. Ravindran, J. Säfholm, A.-C. Orre, M. Al-Ameri, M. Adner, S.-E. Dahlen, J. S. Dahlin, G. Nilsson

The paper identifies 102 cell surface markers on human lung mast cells, showing continuous heterogeneity rather than distinct subpopulations.

bioRxiv · Mar 12, 2021Immunology

Sublingual allergen immunotherapy with recombinant dog allergens prevents airway hyperresponsiveness in a model of asthma marked by vigorous TH2 and TH17 cell responses

J. M. Stark, J. Liu, C. A. Tibbitt, M. Christian, J. Ma, A. Wintersand, B. Murrell, M. Adner, H. Gronlund, G. Gafvelin, J. M. Coquet

This study shows that sublingual immunotherapy with recombinant dog allergens reduces airway hyperresponsiveness and type 2 inflammation in a mouse model of dog allergy.

bioRxiv · Feb 4, 2021Immunology